Future

United

<ul class="list-ic vertical">
 <li><span>1</span> <a>JNJ stock price: The company’s stock price is experiencing slow growth with negative returns</a></li>
 <li><span>2</span> <a>The firm has made an increase of 6.8% in its total deals as compared to last year.</a></li>
 <li><span>3</span> <a>the bulls are trying to push the price toward its immediate resistance, see the levels below</a></li>
</ul>
<p>The New Jersey-based Healthcare company, Johnson &amp; Johnson (NYSE: JNJ), facilitates the research and development, manufacture, and sale of products in the healthcare field. The company operates through different fields such as Consumer Health, Pharmaceutical, and MedTech. The JNJ stock is considered a large-cap stock with a market capitalization of $368B.</p>
<h2 class="wp-block-heading" id="strong-some-highlights-of-the-q3-2023-strong"><strong>Some Highlights of the Q3 2023</strong></h2>
<p>The latest report on deals shows that in the third quarter of 2023, the total deals amounted to $21.4 billion, an increase of 6.8% compared to the same period in 2022. The growth of functional deals without considering currency exchange was 6.4%, with currency exchange having a positive effect of 0.4%. The United States saw an increase of 11.1% in deals, while regions outside the US reported a growth of 1.6%.&nbsp;</p>
<h3 class="wp-block-heading" id="strong-the-cost-cut-strong"><strong>The Cost Cut&nbsp;</strong></h3>
<p>The company reduced selling, marketing, and regulatory expenses by 40 basis points (0.40%) but invested heavily in research and development. It allocated $3.4 billion or 16.2% of the sales in this quarter. Research and development expenses decreased by 1.2% basis, the reason was given to portfolio prioritization. The company also faced IPR&amp;D weaknesses of $206 million in the third quarter.</p>
<h2 class="wp-block-heading" id="strong-technical-analysis-and-prediction-of-the-jnj-stock-price-strong"><strong>Technical Analysis and Prediction of the JNJ Stock Price</strong></h2>
<div class="wp-block-image">
 <figure class="aligncenter"><img decoding="async" src="https://lh7-us.googleusercontent.com/XEfLwKArTsUafW1jS4hYPyONCGA0uWCUX7klGL3M4g2Vkmxze_cgghSWyR4CLx982faRxQWRfAiJf35-17qA0SyFjAYbXJnxNjZdDkKi6FGtubmGD7SK_H7dfqK4V4m3gGNuuir8pvi6rbLurs2OTho" alt="JNJ Stock Price: Investors Alert, Stock is Reclaiming Its Support">
  <figcaption class="wp-element-caption">
   Chart provided by<a href="https://in.tradingview.com/chart/X78t0Vyp/?symbol=NYSE%3AJNJ" rel="noopener noreferrer nofollow"> Tradingview </a>(weekly time frame)
  </figcaption>
 </figure>
</div>
<p>Since JNJ is a large-cap stock, the growth hasn’t been quite impressive for 2 years. The JNJ stock price has given a return of -6.5% since October 2021. Bulls reached a high of $179 in August 2021 and the RSI reached its overbought level, causing price correction. When the stock took the support of the $158 level, it rose again. This time, it broke the past high by reaching $186. The stock has been in a consolidation phase since then.&nbsp;</p>
<h3 class="wp-block-heading" id="strong-present-and-possible-future-strong"><strong>Present and Possible Future</strong></h3>
<p>At the press time, the JNJ <a href="https://www.thecoinrepublic.com/2023/10/15/backed-by-strong-financials-cey-stock-price-rose-11-6-in-5-days/" rel="noopener noreferrer nofollow">stock price</a> is in a downtrend. It is currently trading at the level of $153 after coming back from the support level of $150 as the bulls are trying to push the price towards its immediate resistance of $159. The second resistance is situated at $164. The EMAs seem to be posing a challenge.</p>
<p>The 50-day EMA is at $159 and the 150-day EMA is at $162. They have made a bearish crossover indicating a weak strength in the price. However, if the bulls surpass the first resistance, the trend may reverse as the downtrend line will be broken. If things go south, the price will fall to the 2nd support of $144.</p>
<h3 class="wp-block-heading" id="strong-conclusion-strong"><strong>Conclusion</strong></h3>
<p>Johnson &amp; Johnson (NYSE: JNJ) is a multinational healthcare company. It has reported some positive highlights in its recent quarter 3 earnings report. The JNJ stock price is trading at its support level and it is expected to make a high.</p>
<h4 class="wp-block-heading"><strong>Technical Levels</strong></h4>
<ul>
 <li><strong>Support:</strong> $153, and $144</li>
 <li><strong>Resistance: </strong>$159, and $164</li>
</ul>
<h5 class="wp-block-heading"><strong>Disclaimer</strong></h5>
<p>The views and opinions stated by the author, or any people named in this article, are for informational purposes only. They do not establish financial, investment, or other advice. Investing in or trading in stocks or related indexes comes with a risk of financial loss.</p>

JNJ Stock Price: Investors Alert, Stock is Reclaiming Its Support

Table of Contents

Thecoinrepublic.com

Other articles published on Oct 22, 2023

Bitcoin SV (BSV) Skyrockets by More Than 58% This Week Amid New Binance Perpetual Contract Listing

Defimons Characters: The Gaming NFT with Varied Hidden Traits

Coinbase optimistic about US approval of Bitcoin ETF

Uniswap’s HayCoin Soars to $4M after Founder’s Dramatic Token Burn!

Shiba Inu Targets $0.00000635 As It Faces Bearish Exhaustion

Harnessing AI to Promote Diversity on College Campuses

Join our free newsletter for daily crypto updates!